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Substance-related and addictive disorders as mediators between Borderline Personality Disorder and aggressive behaviour
Impulsivity is considered a core clinical feature in Borderline Personality Disorder (BPD). Evidence also indicates that impulsivity is part of the biological vulnerability of BPD. The purpose of the study was to verify the presence if the presence of Substance-Related and Addictive Disorders (SRAD) may enhance impulsivity and aggression in BPD. Eighty patients (27 with BPD, 26 with BPD and SRAD, 27 with Other PD) completed a comprehensive assessment for personality disorder symptoms, impulsivity, and aggressive behaviour. BPD patients with SRAD showed higher scores on impulsivity and aggression compared to other groups. Furthermore, no significant difference was observed between BPD and OPD patients on impulsivity and aggression. The presence of SRAD was found to be a mediator between BPD and impulsive and aggressive behaviour. The findings are discussed and directions fir future research presented.
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Key Points: 
-	No differences on impulsivity and aggressive behaviour were observed in patients with BPD and patients with OPD.
-	Patients with BPD and concurrent SRAD showed greater impulsivity and aggressive behaviour compared to patients with only a BPD diagnosis.
-	SUD emerges as a mediating factor between both BPD diagnosis and impulsivity, and BPD and aggressive behaviour.

1. Introduction
Borderline Personality Disorder (BPD) is characterized by problematic clinical features such as impulsivity, emotional instability, interpersonal difficulties and cognitive dysfunctional process (American Psychiatric Association, 2013). These clinical features have a strong detrimental impact on general functioning (Skodol et al., 2002), treatment compliance (Chiesa, Martino, & Pozzi, 2010; Martino, Menchetti, Pozzi, & Berardi, 2012), physical health status (Douzenis, Tsopelas, & Tzeferakos, 2012) and relationships with relatives and peers (Martino et al., 2014). 
Impulsivity in BPD is thought to be a central symptom and key component of the disorder (Moeller, Dougherty, Schmitz & Swann, 2001). The clinical concept of impulsivity is diffuse and is usually measured by self-report instruments (Lieb, Zanarini, Schmahl, Linehan, & Bohus, 2004). Research has shown that impulsivity is higher in BPD compared to healthy controls (Berlin, Rolls, & Iversen, 2005; Domes et al., 2006; Kunert, Druecke, Sass, & Herpertz, 2003; Paris et al., 2004; Rentrop et al. 2008). In contrast, neuropsychological and behavioural measures of impulse behaviours overlap only partially with impulsivity as assessed by self-report. Behavioural impulsivity is measured by a variety of experimental paradigms, such as response inhibition, cognitive and interference inhibition, and decisional impulse control. Evidence appears to suggest (Le Gris Links, van Reekum, Tannock, & Toplak, 2012) that behavioural response inhibition, mainly measured by simple Go/no-go- and Stop-signal paradigms, is only weakly affected in BPD. Conversely, cognitive and interference inhibition appears to be affected in BPD (Sebastian, Jacob, Lieb & Tüscher, 2013) but the results are mixed and currently remain rather inconclusive. 
The discrepancy between the clinical perception of impulsivity and data from laboratory research can be explained (at least in part) by the variety of measures employed in research, such as self-report, behavioural and neurophysiological measures. A further explanation lies in the lack of a unified definition of impulsivity which has come to include distractibility and a short attention span, the need to seek stimulation and novelty, susceptibility to boredom, acting without forethought, and emotionally triggered rash action (Depue & Collins 1999; Whiteside & Lynam 2001; Zapolski, Settles, Cyders, & Smith, 2010). 
To complicate further the picture, it has been argued that the aforementioned discrepancy may be due to affective dysregulation (Clarkin, Hull, & Hurt, 1993), which a central feature in BPD. This may drive problematic behaviours, such as substance use, as a means of reducing such unpleasant emotions, resulting in increased impulsivity and behavioural dyscontrol (Chmielewski, Bagby, Quilty, Paxton, & McGee Ng,  2011; Linehan, 1993; Selby & Joiner, 2009). 
In support of this view, research has shown that  patients with BPD present with high rates of co-occuring substance-related and addictive disorders (SRAD) (Bornovalova, Lejuez, Daughters, Zachary Rosenthal, & Lynch, 2005; Trull,  (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed?term=Trull%20TJ%5BAuthor%5D&cauthor=true&cauthor_uid=10721499​)Sher, (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed?term=Sher%20KJ%5BAuthor%5D&cauthor=true&cauthor_uid=10721499​) Minks-Brown,  (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed?term=Minks-Brown%20C%5BAuthor%5D&cauthor=true&cauthor_uid=10721499​)Durbin,  (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed?term=Durbin%20J%5BAuthor%5D&cauthor=true&cauthor_uid=10721499​)& Burr, (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed?term=Burr%20R%5BAuthor%5D&cauthor=true&cauthor_uid=10721499​) 2000) resulting in more severe symptoms, frequent self-harm and suicide attempts (Links, Heslegrave, Mitton, van Reekum, & Patrick, 1995; Zanarini, Frankenburg, Hennen, Reich, & Silk, 2004 ). There is a large body of literature (for a review see Perry & Carroll 2008) showing that this association is reciprocal. 
In relation to BPD, some authors (Linehan, 1993; Martino, Caselli, Ruggiero, & Sassaroli, 2013; Selby, Anestis, & Joiner, 2008; Selby & Joiner, 2009; Martino et al., 2015) have suggested that problematic behaviours, such as SRAD, may arise due to emotional and cognitive dysregulation. In other words the use of substances to alter mental state may become habitual (through their negative reinforcement properties)  and lead to the development of SRAD. Longer term, however, the presence of SRAD will typically bring to a reduction in the ability to control behaviours, enhancing the likelihood of impulsivity and aggression. 
On the basis of these considerations and in ine with previous theoretical models (Linehan, 1993; Selby et al., 2008; Selby at al., 2009) we hypothesized that:
•	Impulsivity and aggression would be higher in BPD and SRAD (Dual Diagnosis, DD) compared with other personality disorders (OPD) or BPD only; and
•	A BPD diagnosis would predict impuslvity and aggression and this relation would be mediated by SRAD. 






Ninety-two cases with a diagnosis of personality disorder who had accessed the Bologna Community Mental Health Centre (BCMHC) over a one year period were offered the opportunity to take part in a study. Potential participants  were evaluated through a comprehensive assessment procedure  described in previous studies (Chiesa et al. 2010; Martino et al. 2012; Pozzi, Ridolfi, Daniel, Manganaro, & Berardi, 2008).  All patients had to be at least 18 years old and meet criteria for personality disorders. Exclusion criteria were: the presence of intellectual disability, severe psychotic symptoms, and reported difficulties in understanding written or spoken Italian language.
	Patients who met the above criteria were informed about the study and provided a consent form. The study was described to all participants as an investigation of their personality and other clinical features (substance use, aggression, impulsivity). Patients were are also informed that after their initial evaluation they would be given feedback and outlines of proposed treatments. All participants were informed that data were to be anonymized and that participation in the research project was voluntary. Informed consent, for participating in the study, was obtained from all patients included in the study. The study was approved by the Ethical Committee of the Bologna Local Health Unit (EC code: 13073). 			
	Patients who were selected for the present study were evaluated trough a sociodemographic form and a psychometric assessment package, composed of: 	(a) The Structured Clinical Diagnostic Interview for DSM-IV – Axis II (SCID II) (First, Gibbon, Spitzer, Williams, & Benjamin, 1997); (b) the Aggression Questionnaire (AQ) (Buss & Perry, 1992; Fossati, Maffei, Acquarini, & Di Ceglie, 2003); the Barratt Impulsiveness Scale (BIS-11)  (Fossati, Di Ceglie, Acquarini, & Barratt, 2001). Clinical interviews (SCID-II) were conducted by trained psychiatric physicians, all of whom have extensive experience assessing personality disorders. 
	The final sample included 80 participants: (a) 27 patients with BPD only, without current SRAD; (b) 26 patients with BPD and current SRAD (Dual Diagnosis, DD); and (c) 27 patients with Other Personality Disorder (OPD) that did not meet lifetime diagnostic criteria for BPD or SRAD. Patients with SRAD reported current use of alcohol (n=6), sedatives (n=4), opiates (n=4), marijuana (n=7), amphetamine (n=2), and cocaine/crack (n=3). The OPD group was composed of 6 patients with Cluster A PD (1 schizoid, 3 schizotypal, 2 paranoid), 10 patients with a Cluster B PD (5 narcissistic, 5 histrionic), 9 patients with Cluster C PD (4 Avoidant, 2 Obsessive Compulsive, 3 Dependent) and 2 with a Personality Disorder not otherwise specified (PDNOS). No antisocial patients were referred to the study. The majority of the patients were female (n=68; 85%) and the mean age was 36.6 years (SD=11.08 years). Regarding marital status, patients were mostly single (n=46; 57.5%). There were no gender differences in substances use, and participants with a SRAD were 22 females (32% of female sample) and 4 males (33% of male sample). Males showed higher scores for both impulsivity (Mean= 47.6 V Mean= 44.3) and aggression (Mean=98.2 V Mean=81. 1) compared to females.
2.2. Measures 
2.2.1. Aggression Questionnaire (AQ; Fossati et al., 2003)
The AQ is a 29 Likert-type, self-report questionnaire which measures four components of aggressiveness: (1) physical aggression (e.g. “Given enough provocation, I may hit another person” or “I get into fights a little more than the average person”); (2) verbal aggression (e.g. “I can’t help getting into arguments” or “I often find myself disagreeing with people”; (3) anger (e.g. “Sometimes I fly off the handle for no good reason” or “I sometimes feel like a powder keg ready to explode”); and (4) hostility (e.g. “I wonder why sometimes I feel so bitter about things” or “At times I feel I have gotten a raw deal out of life”). The total score for all subscales was used to measure an overall tendency to aggression with higher scores indicating higher levels of aggression. In the current study the AQ Cronbach’s alpha was .88.
2.2.2. The Barratt Impulsiveness Scale-11 (BIS-11; (Patton, Stanford, & Barratt, 1995).
The BIS-11 is a 30 item, Likert-type, self-report questionnaire which measures three subtypes of impulsivity: behavioural impulsivity; cognitive impulsivity; non-planning impulsivity. The total score for all subscales was used to measure an overall tendency to impulsivity with higher scores indicating higher levels of impulsivity. In the current study the BIS-11 Cronbach’s alpha was .79.
2.2.3. Substance-related and addictive disorders data
This was collected by the senior psychiatrist and is characterized by the intermittent, indiscriminate and non-dependent use of many substances (poly-abuse), such as alcohol, sedatives, opiates, marijuana, amphetamine, cocaine/crack. The dichotomous variable referred to the presence or absence of a current substance use behaviour. 
2.3. Data Analysis 
Statistical analyses were carried out using SPSS version 17.0 for Windows. Gender differences were obtained using the cross tabulation and t-test analyses. Group differences on impulsivity and aggression were examined using ANOVA. When multiple comparisons were needed, Bonferroni post-hoc tests were used. Before running regression analysis, data configuration was conducted. First, correlation analyses showed significant correlations between all measures (aggression, impulsivity and SRAD). Subsequently, an inspection of graphical distribution of D2 on Q–Q plots for each variable indicated a multivariate normal distribution. We then examined multi-collinearity using the tolerance index (Ti) and the variance inflation factor (VIF) for all variables. This was as follows: Borderline Personality Disorder index (Ti= 0.82; VIF=1.21) and SRAD (Ti= 0.82; VIF=1.21). These analyses supported the absence of multicollinearity between variables. Furthermore, an inspection of correlation coefficients (Durbin-Watson index=1.87) showed that there were no significant correlation between standardized residuals and independent variables. In order to implement a mediational analysis (Baron & Kenny, 1986; Cohen, 1988) we firstly examined the multicollinearity between variables. Subsequently we implemented linear regression analysis in order to test the hypothesis. We ran the first hierarchical regression analysis with behavioural impulsivity as the dependent variable to analyse the mediational effect of SRAD on the relationship between BPD diagnosis and behavioural impulsivity. Furthermore we ran a second hierarchical regression analysis with aggression as the dependent variable to verify the role of SRAD in mediating the relationship between BPD diagnosis and aggressive behaviour. Finally, the Sobel test was administered to ascertain the significance of the meditational models.
3. Results
Data showed significant differences in impulsivity and aggression between the three groups (BPD, DD, OPD) (see Table 1). Regarding aggression proneness, the DD group showed an overall higher score compared to the BPD group (F=9.39; p<0.001). Patients with BPD were found to only be not more aggressive than the OPD subgroup (F=9.39; p<0.35). Regarding impulsivity, data showed a higher behavioural (F=6.76; p<0.001) and cognitive (F=8.28; p<0.001) score in DD patients compared to BPD patients. In addition, BPD patients were the only group who did not show greater impairment in cognitive (F= 8.28; p< 1.00) and behavioural (F=6.76; p<1.00) impulsivity compared to the OPD group. No differences were found in dthe ecision making component of impulsivity amongst the three groups (F= 1.56; p<0.22).
3.1. Hierarchical Regression Analyses
In the first hierarchical regression analysis (see Table 2), BPD diagnosis was entered as an independent variable and it was found to be a significant predictor of behavioural impulsivity (dependent variable). Subsequently, SRAD variable was added to the second step of this analysis. As SRAD had a significant effect on impulsivity and BPD diagnosis lost its impact on the dependent variable (in the second step of regression), this would confirm that SRAD plays a full mediating role between BPD diagnosis and impulsivity. The Sobel test was also statistically significant (z=3.20, p<0.01) confirming the mediation of SRAD in the relationship between BDP diagnosis and impulsivity. 
In the second hierarchical regression analysis model (see Table 3), BPD diagnosis was as an independent variable and it was found to be a significant predictor of aggression (dependent variable). Subsequently, SRAD was added to the second step of this analysis. As SRAD had a significant effect on aggression and the BPD diagnosis lost its impact on the dependent variable (in the second step of regression), this would confirm that SRAD plays a full mediating role between BPD diagnosis and aggression. The Sobel test showed that the indirect effect of the independent variable on the dependent variable was significant (Z=3.39; p<.01), thus supporting a mediating effect. 
In order to further test our hypotheses, we implemented two hierarchical logistic regression analyses with SRAD as dependent variable and BPD diagnosis (step 1) and impulsivity and aggression (step 2) as predictor variables. In the first regression model BPD diagnosis predicted SRAD (R2=.33; β=.58; p=.00). When impulsivity was inserted on the second step, however, BPD diagnosis still remained significant in predicting SRAD, whilst impulsivity did not add significant variance to the relationship (R2=.32; β=.01.; p=.93). Conversly, when aggression was added to the second step of the second regression model, it showed to have an impact on SRAD (R2=.37; β=.24; p=.01) but BPD diagnosis did not lose its significant effect in predicting SRAD. Thus, even though aggression was found to have a significant impact on SRAD it was not a mediator in this model. 
4. Discussion
The present study focused on the influence that SRAD have in determining impulsivity and aggressive behaviours in people with BPD. First, we explored gender differences in impulsivity and aggression and substance use behaviours. Even though impulsivity and aggression were found to be higher in males, and in accordance with previous findings (Zlotnick, Rothschild & Zimmerman, 2002), there were no significant differences between male and female in substance use behaviours. This finding needs further investigation, considering the small male sample (n=4) which participated in our study. Second, we examined the presence of impulsivity and aggression in people with BPD only, BPD and SRAD and OPD. Our findings did not show that patients with BPD scored higher than OPD patients on impulsivity and aggressive behaviour, since no significant group differences emerged on these measures. The absence of significant group differences between BPD and OPD patients could also be due to the presence of patients with other cluster B Personality Disorders (histrionic and narcissistic) within the OPD sample, characterized by, as well as BPD patients, higher levels of impulsivity and aggressive behaviours compared to other personality disorders.
However, interestingly, data showed significant group differences between patients with BPD only and patients with BPD and concurrent SRAD (DD), on both measures of aggression and impulsivity (cognitive and behavioural). These results indicate that BPD patients do not show more impulsivity and aggressive behaviour compared to patients with other personality disorders (at least on self-report measures), but when having a comorbidity with SRAD, these features are significantly higher. Therefore, it can be hypothesized that impulsivity and aggressive behaviour are aggravated by SRAD, rather than being core features of BPD. There are indeed some studies suggesting that problematic substance use may render the psychopathology and clinical outcomes of BPD more serious. For example, problematic substance use can contribute to several BPD criteria, including dissociation, affective instability, impulsivity, and interpersonal problems (Carpenter, Wood, & Trull, 2015). Links and colleagues (1995) have also found that individuals with both BPD and SRAD displayed more severe BPD psychopathology, including self-destructive and suicidal tendencies at 7-year follow-up, relative to those whose initial diagnosis was BPD or SRAD only. Another study reported that young BPD patients with comorbid SRAD were more impulsive than BPD patients without any history of SRAD (Wilson et al., 2007). 
In conclusion, our data support evidence showing how SRAD may exacerbate symptoms in BPD patients. Furthermore, the present findings confirmed that SRAD emerges as a mediating factor between both BPD diagnosis and impulsivity, and BPD and aggressive behaviour. These results highlight how a problematic use of substances may foster impulsive and uncontrolled behaviour in people with BPD. Even though impulsivity and aggression are often present in BPD patients they may not have a direct impact of substance use, but they may drive other problematic behaviours (such as self-harm or binge eating). From our findings we can argue that impulsivity and aggression may have an impact on SRAD but it may well be that other components (such as emotional dysregulation, or rumination) of a BPD diagnosis could be superior predictors of SRAD. Conversely, the problematic use of substances in our sample showed an increased score on impulsivity and aggression and had a role in mediating the relationship between BPD diagnosis and impulsive and aggressive behaviours.
Some authors (Fossati, Gratz, Maffei, & Borroni, 2014; Sebastian et al., 2013) support the idea that impulsive behaviours in BPD might also depend on emotional dysregulation rather than solely on impulsive traits. Negative emotions might differentially affect certain components of impulse control which might account for the heterogeneous findings. Research conducted by Axelord and colleagues (Axelrod, Perepletchikova, Holtzman, & Sinha, 2011), in support of this view, found that improvement in emotion regulation in BPD patients, following Dialectical-Behavioral Therapy (DBT) (Lee, Cameron, J., & Jenner, 2015), accounted for improvement in impulsive and maladaptive behaviour (substance use). Therefore, future studies should include specific tools for assessing emotional dysregulation in order to confirm the influence of this process on the emergence of SRAD and problematic behaviours.
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Table 1:  Differences between Borderline Personality Disorder, Other Personality Disorder and Dual Diagnosis groups on Impulsivity and aggression.

	BPD (N=27)M (sd)	OPD (N=27)M (sd)	DD (N=26)M (sd)	F; p*
Behavioural Impulsivity	23.29 (4.85)	23.44 (7.00)	28.30 (4.70)	6.76 **
Cognitive Impulsivity	14.41 (3.05)	14.33 (4.13)	17.73 (3.07)	8.28 **
Non-Planning 	27.67 (4.52)	27.33 (5.86)	29.69 (5.25)	1.56; NS
Aggression     	81.56 (20.46)	72.62 (24.74)	96.92 (14.98)	9.4 **
 Note: *p<.05, **p<001, NS: No Significant; Borderline Personality Disorders (BPD), Other Personality Disorders   (OPD); Dual Diagnosis (DD), Aggression Questionnaire (AQ).  

Table 2: Linear regression analysis with behavioural impulsivity as the outcome variable and DBP diagnosis and Substance-Related and Addictive Disorders as independent variables.

Step	R	Adj R2	Change R2	F Change	Df	Sig of F Change




Borderline Personality Disorder (BPD), Other Personality Disorders (OPD); Dual Diagnosis (DD), Substance-Related and Addictive Disorders (SRAD).
Model	B	SE	β	t	Sig
1 - BPD	.68	.25	.30	2.78	.01
2 - BPD    SRAD	.264.11	.291.66	 .12.32	0.892.48	.38.02

Table 3: Linear regression analysis with aggression as the outcome variable and DBP diagnosis and Substance-Related and Addictive Disorders as independent variables.

Step	R	Adj R2	Change R2	F Change	Df	Sig of F Change
Block of variables 						
1-BPD 	.34	.11	.12	10.23	1	.01
2-BPD/SRAD	.43	.17	.07	6.35	1	.01
Borderline Personality Disorder (BPD), Other Personality Disorders (OPD); Dual Diagnosis (DD), Substance abuse disorder (SRAD).Model	B	SE	β	t	Sig
1- BPD	2.92	.91	.34	3.20	.01
2- BPD    SRAD	1.3415.40	1.086.11	 .16.32	1.232.52	.22.01




